Literature DB >> 7999370

Evolution of glutamine synthetase genes is in accordance with the neutral theory of molecular evolution.

Y Tateno1.   

Abstract

Evolution of glutamine synthetase gene is discussed on the results of DNA sequence analysis of the gene. Thirty DNA sequences of various organisms spanning from prokaryotes to eukaryotes were collected from the DNA data banks and translated first, they were aligned next, then evolutionary distances were computed, and molecular phylogeny was finally estimated. The results of the alignment reveal that functionally important regions of glutamine synthetase have been evolutionarily more conserved than the remaining regions. The evolutionary distances computed also show that the rate of synonymous substitution is higher than that of nonsynonymous substitution. These are well in accordance with the neutral theory of molecular evolution. Besides, the molecular phylogeny obtained shows that the origin of glutamine synthetase gene is much earlier than the divergence between eukaryotes and prokaryotes, suggesting that the gene is one of the oldest genes functioning now.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7999370     DOI: 10.1266/jjg.69.489

Source DB:  PubMed          Journal:  Jpn J Genet        ISSN: 0021-504X


  3 in total

1.  Genetic diversity of elite rhizobial strains of subtropical and tropical legumes based on the 16S rRNA and glnII genes.

Authors:  Ilmara Varotto Roma Neto; Renan Augusto Ribeiro; Mariangela Hungria
Journal:  World J Microbiol Biotechnol       Date:  2010-01-08       Impact factor: 3.312

2.  A revised view on the evolution of glutamine synthetase isoenzymes in plants.

Authors:  José Miguel Valderrama-Martín; Francisco Ortigosa; Concepción Ávila; Francisco M Cánovas; Bertrand Hirel; Francisco R Cantón; Rafael A Cañas
Journal:  Plant J       Date:  2022-03-09       Impact factor: 7.091

3.  Glutamine synthetase sequence evolution in the mycobacteria and their use as molecular markers for Actinobacteria speciation.

Authors:  Don Hayward; Paul D van Helden; Ian J F Wiid
Journal:  BMC Evol Biol       Date:  2009-02-26       Impact factor: 3.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.